Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NCQ 436

Known as: Benzamide, 3-bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-5,6-dihydroxy-2-methoxy-, (S)-, NCQ-436 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Remoxipride is an atypical antipsychotic displaying selective binding to the dopamine D2 receptor. Several cases of aplastic… Expand
1997
1997
The in vivo effects of remoxipride, in relation to some of its identified metabolites, were investigated in adult male Sprague… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
1994
1994
The effect of remoxipride ((S)(-)3-bromo-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2,6-dimethoxybenzam ide) on dopamine D2 receptor… Expand